FromAstraZeneca ([email protected])
Subject (107)AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
Preheader (106)AstraZeneca aims to transform cancer outcomes with new data across industry-leading portfolio at ESMO 2022
Arial
Text Analysis
Body Words219
Subject Words15
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images7
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px786 px
X-Spam Score-0.1
Preheader OptimizedNo
Timing
Day of WeekFriday
TimeAfternoon
